Back to News
Market Impact: 0.25

UK's Schroders examines options for Benchmark business, sources say

PWP
M&A & RestructuringPrivate Markets & VentureManagement & GovernanceCompany FundamentalsCorporate Guidance & OutlookAnalyst InsightsInvestor Sentiment & Positioning
UK's Schroders examines options for Benchmark business, sources say

Schroders is exploring strategic options, including a potential sale, for its financial planning arm Benchmark Capital and has hired advisers including Perella Weinberg Partners to run the process, though discussions are at an early stage and may not lead to a sale. Benchmark manages £37.1bn of AUM and serves over 1,000 adviser clients in the mass-affluent segment; private equity firms have shown interest, while Schroders says it may instead retain and accelerate Benchmark’s growth as part of its multi-year wealth strategy. The move follows Schroders' October exit from its Lloyds mass-affluent JV and highlights a re-shaping of its wealth footprint amid differing profitability profiles between Benchmark and Cazenove.

Analysis

Market structure: A sale of Benchmark (AUM £37.1bn) crystallises value from Schroders (SDR.L) and signals growing bifurcation between high-margin affluent wealth (Cazenove) and lower-margin mass-affluent platforms. Winners: private equity buyers (opportunity to scale fees via consolidation) and Schroders if proceeds >3-5% of market cap are redeployed into higher-return initiatives; losers: standalone mass-affluent operators (pressure on margins, talent poaching). Expect modest short-term AUM volatility and potential re-rating of UK wealth peer multiples over 3–12 months as buyers price in integration risk and client attrition rates (10–20% worst-case within 12 months post-sale). Risk assessment: Tail risks include deal collapse leading to a 10–20% negative share move for SDR.L, regulatory scrutiny on buyer consolidation, or material client outflows from Benchmark post-sale (second-order hit to fee income). Immediate (days) risk is headline-driven volatility; short-term (weeks–months) risks are due diligence leaks and PE bid/auction dynamics; long-term (quarters–years) are execution—retention of adviser clients and integration. Key hidden dependencies: earn-outs, client transferability clauses, and Lloyds-Cazenove JV unwind liabilities that could shave 50–150bps off expected returns. Trade implications: Tactical long on SDR.L into a sale announcement priced for a 5–15% upside if proceeds redeployed or returned; hedge with a 6-month 10% OTM put protection or buy 6–9 month 10%/20% call spreads to cap cost. Relative trade: long SDR.L (1.5–2% position) vs short Hargreaves Lansdown (HL.L) or St. James's Place (STJ.L) 1%—expect differential margin expansion if Schroders reallocates capital to Cazenove. Rotate 1–3% from standalone mass-affluent platforms into diversified asset managers with scale (SDR.L, ANZ/UBS wealth exposure) over next 3–9 months. Contrarian angles: Consensus may treat a divestment as de-risking and neutral; we see upside if sale fetches >0.5% of AUM in price (i.e., >£185m) and is redeployed to higher-margin growth—market underappreciates optionality of bolt-on M&A for Cazenove. Historical parallels: asset managers selling retail units often re-rate when capital is returned/ redeployed (e.g., divestments in 2015–2018); unintended consequence is PE strip that accelerates adviser churn, so size your positions with 8–12% stop-loss and monitor client retention metrics within 90 days post-close.